Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Marqeta Inc (MQ) vs Koninklijke Philips NV (PHG) Price & Performance

Marqeta IncTrade
Koninklijke Philips NVTrade

Price performance (Past 24H)

Key statistics

Marqeta Inc vs Koninklijke Philips NV — how do they compare? Marqeta Inc trades at $15.94 (market cap $1.69B), while Koninklijke Philips NV trades at $24.94 (market cap $24.84B). The key difference: Koninklijke Philips NV is far larger — about 14.7× Marqeta Inc's market cap, and Koninklijke Philips NV pays a 4.01% dividend while Marqeta Inc pays none. Which is the better fit depends on your goals.

MQPHG
Market Cap
$1.69B$24.84B
Sector
TechnologyHealth
52-Week High
$23.88$32.91
52-Week Low
$15.04$25.02
Enterprise Value
$1.01B$31.44B
Dividend Yield
4.01%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Marqeta Inc

Marqeta (MQ) trades at $16.26, down 1.93% on the day, with a bearish technical signal from moving averages. The company shows improving fundamentals with three consecutive quarterly earnings beats and positive net cash flow of $86.42M in 2025. Recent developments include expansion of Google Wallet partnership and stablecoin card initiatives. Valuation metrics remain elevated with P/E of 180.89 and EV/EBITDA of 48.53 despite modest profitability margins.

MQ offers 26% upside to consensus price target of $19.00, supported by earnings estimate revisions and strategic partnerships. Key risks include high valuation multiples, competitive payment processing landscape, and the need to sustain recent profitability improvements. Institutional sentiment leans cautious with 59% hold ratings despite recent business momentum.

Koninklijke Philips NV

PHG trades at $25.29, down 2.32% today, with a bearish technical signal but strong recent earnings beats. The company reported Q2 2026 EPS of $0.57 versus $0.40 expected, continuing a trend of profitability after a turnaround from losses in prior years. Recent news highlights product launches in health technology and a $33.7 million award for AI-enabled stroke care (Business Wire, 2026-08-26).

The outlook is mixed: fundamentals show improving margins and cash flow, but technical indicators and a majority hold analyst rating suggest near-term caution. Key risks include competitive pressures and execution of growth initiatives, while institutional buying activity indicates underlying confidence.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Marqeta Inc

Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.

Read more on MQ

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG